Viewing Study NCT05033769


Ignite Creation Date: 2025-12-24 @ 11:06 PM
Ignite Modification Date: 2025-12-31 @ 12:29 PM
Study NCT ID: NCT05033769
Status: UNKNOWN
Last Update Posted: 2023-04-18
First Post: 2020-06-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Assessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer
Sponsor: Institut fuer Frauengesundheit
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module